InvestorsHub Logo
Followers 1
Posts 169
Boards Moderated 0
Alias Born 07/28/2019

Re: None

Monday, 08/26/2019 3:36:00 PM

Monday, August 26, 2019 3:36:00 PM

Post# of 390
I exchanged a e-mail with the Stil VP:Corporate Dev/Founder, Stillcanna Inc, Marc Crimeni, going through the IR department about particular molecular Isolates and mixes.

"Michael,

Thank you for your inquiry, we do have a centrifugal chromatography machine that can be calibrated to isolate various molecules present in our input material.

We are looking at first the health and wellness products, irregular CBD type tinctures, then nutraceuticals, then pharmaceuticals. Isolation of these molecules is not too faybeyond our reach. We also understand that the hemp seed hull possesses a great deal of Cannabisin B.

We are have some pharmaceutical awareness and understand the molecules you have address have certain cancer fighting capabilities, anti inflammatory properties and more. I would suggest Q1 2020 we would have some band width to further discuss this avenue of research."

www.sciencedirect.com/science/article/pii/S0308814612018468

Dr. Chen's team has about the most definitive study cases concerning Cannabisin B and a few other 'Cannabis' molecules as well that have been put out in Abstract. Another I mentioned was Cannaflavin A. Some of these molecules are present in low percentages, but have a high potential- not much needed(compared to a general CBD and in fact studies show over dosage declines the benefit effect) for dosages. While no company can make any medical claims at present... by 2021-2022... these are 'the next big thing' without a doubt. Specific applications without claims(medical) for Anti inflammatory, Cancer treatments and, imo, LDL prevention(Heart disease/plaque buildup) are the brass rings in this expansion into Endocannabinoids. What is most required outside of desire to participate in these particular molecules, is very large Biomass volumes. Which Stil is developing and perhaps next year working towards, very exciting if the Stil team develops a parallel Isolation system(as of now I am not aware of the ability to do all the molecules with only a Ethanol extraction... while some of the extractions done with other solvents can be 'cleaned up/those solvents removed with additional passes through a Ethanol system making a very reliable food grade product.
As always, one thing before another in a startup company but it is good to know that Stil management is fully aware and considering these steps to carry the company forward into 2021+ with what, imo/numbers, can equal almost the next two year plan for general CBD.